Results 41 to 50 of about 3,561 (170)

Management of Pneumocystis Jirovecii pneumonia in HIV infected patients: current options, challenges and future directions [PDF]

, 2010
Jose G Castro1, Maya Morrison-Bryant21Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, Florida, USA; 2Jackson Memorial Hospital/University of Miami Infectious Diseases Fellowship Program, Miami, Florida, USAAbstract:
Jose G Castro, Maya Morrison-Bryant
core   +2 more sources

Laboratory-based surveillance of Pneumocystis jirovecii pneumonia in South Africa, 2006–2010i

Southern African Journal of Infectious Diseases, 2016
Background: We aimed to establish the characteristics of patients with confirmed Pneumocystis jirovecii pneumonia recruited by passive, sentinel laboratory-based surveillance.
Desiree du Plessis, Bhavani Poonsamy, Veerle Msimang, Leigh Davidsson, Cheryl Cohen, Nelesh Govender, Halima Dawood, Alan Karstaedt, John Frean   +8 more
doaj   +1 more source

Anti-Pneumocystis carinii and antiplasmodial activities of primaquine-derived imidazolidin-4-ones [PDF]

, 2008
A series of primaquine-derived imidazolidin-4-ones were screened for their in vitro activity against Pneumocystis carinii and Plasmodium falciparum W2 strain. Most compounds were active against P.
Jiri Gut, Margaret S Collins, Melanie T Cushionc, Nuno Vale, Paula Gomes, Philip J Rosenthal, Ricardo Ferraz, Rui Moreira   +7 more
core   +1 more source

Safety of sulfamethoxazole–trimethoprim for the treatment of bacterial infection in outpatient settings: A systematic review and meta‐analysis with active comparator disproportionality analysis

British Journal of Clinical Pharmacology, Volume 91, Issue 6, Page 1632-1648, June 2025.
Aims Sulfamethoxazole–trimethoprim (SMX‐TMP) is a widely used antibiotic for treating bacterial infections, but its safety in adult outpatients remains understudied. This systematic review and meta‐analysis evaluated the safety profile of SMX‐TMP and identified critical research gaps.
Rebecca Preyra, Lujain Ez Eddin, Fatemeh Ahmadi, Atefeh Jafari, Flory T. Muanda   +4 more
wiley   +1 more source

Abstract Book for the 27th Congress of the European Hematology Association

, 2022
HemaSphere, Volume 6, Issue S3, Page 1-4130, June 2022.
wiley   +1 more source

Diagnosis of Granulomatosis With Polyangiitis in a 39‐Year‐Old Woman With a Recent History of Traveling to Malaria‐Endemic Region: A Case Report

Clinical Case Reports, Volume 13, Issue 3, March 2025.
ABSTRACT Granulomatosis with Polyangiitis (GPA) is a rare vasculitis that can complicate the diagnostic process, especially in patients with complex medical histories. This case report details a 39‐year‐old woman with situs inversus totalis, Kartagener syndrome, and hypothyroidism, who presented to the emergency department with intermittent petechiae ...
Hanie Forouzandeh, Ahmadreza Rajabi, Abbas Ali Torfeh Esfahani, Farzin Khorvash, Mansoor Karimifar   +4 more
wiley   +1 more source

Strongyloidosis Hyperinfection Syndrome in an HIV‐Infected Patient: A Rare Manifestation of Immune Reconstitution Inflammatory Syndrome

Case Reports in Infectious Diseases, Volume 2018, Issue 1, 2018., 2018
Parasitic infections such as Strongyloides stercoralis and HIV have been reported to coexist, particularly in resource‐limited settings such as India. In an immunocompromised host, S. stercoralis can progress to strongyloidiasis hyperinfection syndrome (SHS). However, SHS is not common in patients with advanced HIV disease.
Kartik Natrajan, Mahenderkumar Medisetty, Raviraj Gawali, Ajit Tambolkar, Divya Patel, Vinay Thorat, Nachiket Dubale, Vrushali Khirid, Chinmay Saraf, Ameet Dravid, Larry M. Bush   +10 more
wiley   +1 more source

A Case of Trimethoprim‐Sulfamethoxazole Associated Aseptic Meningitis

Clinical Case Reports, Volume 13, Issue 2, February 2025.
ABSTRACT Most cases of aseptic meningitis, or nonsuppurative meningitis, are caused by viruses or systemic diseases. Nonetheless, drug‐induced aseptic meningitis should be considered in the differential diagnosis, particularly with the recent use of antibiotics and nonsteroidal anti‐inflammatory drugs.
Malik W. Z. Khan, Abdul Moeez, Sameen Farooq, Adam Saeed, Salma Qudrat, Farishta Ali, Faheemullah Khan   +6 more
wiley   +1 more source

Plasma IL‐6/IL‐10 Ratio and IL‐8, LDH, and HBDH Level Predict the Severity and the Risk of Death in AIDS Patients with Pneumocystis Pneumonia

Journal of Immunology Research, Volume 2016, Issue 1, 2016., 2016
Objective. To identify blood biomarkers to predict severity and mortality in AIDS PCP patients. Methods. Biomarkers including clinical parameters and plasma inflammatory cytokines were assessed in 32 HIV‐infected patients with Pneumocystis pneumonia (PCP) at time of admission.
Jia Sun, Junwei Su, Yirui Xie, Michael T. Yin, Ying Huang, Lijun Xu, Qihui Zhou, Biao Zhu, Paola Nistico   +8 more
wiley   +1 more source

Environmental Risk Factors for Pneumocystis Pneumonia Hospitalizations in HIV Patients [PDF]

, 2012
Background. Pneumocystis pneumonia (PcP) is the second leading cause of morbidity and mortality in human immunodeficiency virus (HIV)–infected patients in the United States.
Djawe, K, Fong, S, Grieco, K, Huang, L, Jarlsberg, L, Levin, L, Miller, RF, Roth, B, Subramanian, A, Swartzman, A, Walzer, PD   +10 more
core   +1 more source